CAS 89-25-8
:Edaravona
Descripción:
Edaravona, con el número CAS 89-25-8, es un compuesto sintético reconocido principalmente por sus propiedades neuroprotectoras. Se clasifica como un captador de radicales libres, lo que significa que puede neutralizar radicales libres dañinos en el cuerpo, reduciendo así el estrés oxidativo. Esta característica lo hace particularmente relevante en el tratamiento de enfermedades neurodegenerativas, como la esclerosis lateral amiotrófica (ELA) y el accidente cerebrovascular isquémico agudo. Edaravona se presenta típicamente como un líquido incoloro a amarillo pálido y es soluble en agua, lo que facilita su administración en entornos clínicos. El compuesto tiene un peso molecular relativamente bajo y exhibe un nivel moderado de lipofilia, lo que le permite penetrar eficazmente en las membranas biológicas. Su mecanismo de acción implica la inhibición de la peroxidación lipídica y la protección de las células neuronales del daño oxidativo. Edaravona ha sido estudiado extensamente por su potencial terapéutico, y aunque generalmente es bien tolerado, puede tener efectos secundarios que requieren monitoreo durante el tratamiento.
Fórmula:C10H10N2O
InChI:InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
Clave InChI:InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N
SMILES:O=C1N(N=C(C)C1)C2=CC=CC=C2
Sinónimos:- 1,3,5-Pmp
- 1-Fenil-3-Metil-5-Pirazolona
- 1-Phenyl-3-Methyl-5-Prazalone
- 1-Phenyl-3-Methyl-5-Pyrazole
- 1-Phenyl-3-Methyl-5-Pyrazolone
- 1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one
- 1-Phenyl-3-methyl-2-pyrazolin-5-one
- 1-Phenyl-3-methyl-5-oxopyrazole
- 1-Phenyl-3-methyl-5-pyrazolinone
- 2,4-Dihydro-5-Methyl-2-Phenyl-3H-Pyrazol-3-On
- 2,4-Dihydro-5-Methyl-2-Phenyl-3H-Pyrazol-3-One
- 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazole-3-one
- 2-Pyrazolin-5-one, 3-methyl-1-phenyl-
- 3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one
- 3-Methyl-1-phenyl-1H-pyrazol-5-one
- 3-Methyl-1-phenyl-2-pyrazoline-5-one
- 3-Methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one
- 3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one
- 3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one
- 3-Methyl-1-phenyl-5-pyrazolon
- 3-Methyl-1-phenyl-5-pyrazolone
- 3-Methyl-1-phenylpyrazol-5(4H)-one
- 3-Methyl-1-phenylpyrazol-5-one
- 3-Methyl-1-phenylpyrazole-5-one
- 3-Methyl-1-phenylpyrazolin-5-one
- 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-
- 4,5-Dihydro-3-methyl-5-oxo-1-phenylpyrazole
- 5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one
- 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
- 5-Methyl-2-phenyl-2,4-dihydropyrazol-3-one
- 5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one
- 5-Methyl-2-phenylpyrazol-3-one
- Developer Z
- Edarabone
- Edaravon
- Edaravone
- Edvaradone
- Mci-186
- Methylphenylpyrazolone
- Nci-C 03952
- Norantipyrine
- Norphenazone
- Nsc 12
- Nsc 26139
- Nsc 2629
- PMP
- Phenylmethyl pyrazolone
- Pyrazolin(2)-5-One, 3-Methyl-1-Phenyl-
- Radicava
- Radicut
- C.I. Developer 1
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 17 productos.
3-Methyl-1-phenyl-5-pyrazolone
CAS:Fórmula:C10H10N2OPureza:>98.0%(T)(HPLC)Forma y color:White to Orange to Green powder to crystalPeso molecular:174.203-Methyl-1-phenyl-2-pyrazolin-5-one, 98+%
CAS:<p>3-Methyl-1-phenyl-2-pyrazolin-5-one used as reagent for detection of reducing carbohydrates by ESI/MALDI -MS. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original A</p>Fórmula:C10H10N2OPureza:98+%Forma y color:Pale cream to cream to yellow to pale brown, PowderPeso molecular:174.20Antipyrine Related Compound A (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one)
CAS:<p>Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structure</p>Fórmula:C10H10N2OForma y color:White Pale Yellow PowderPeso molecular:174.07931Edaravone
CAS:<p>Edaravone (MCI-186)(MCI-186) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction.</p>Fórmula:C10H10N2OPureza:99.44% - >99.99%Forma y color:Pale Yellow Solid Solid Particulate/PowderPeso molecular:174.201-Phenyl-3-methyl-5-pyrazolone
CAS:<p>1-Phenyl-3-methyl-5-pyrazolone</p>Fórmula:C10H10N2OPureza:98%Forma y color: yellow crystalline powderPeso molecular:174.20g/mol1-Phenyl-3-methyl-5-pyrazolone
CAS:Fórmula:C10H10N2OPureza:≥ 98.0%Forma y color:White to yellow to brown powder or crystalsPeso molecular:174.205-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone)
CAS:Fórmula:C10H10N2OForma y color:NeatPeso molecular:174.203-Methyl-1-phenyl-2-pyrazolin-5-one(Edaravone)
CAS:Producto controlado<p>Impurity Phenazone EP Impurity A<br>Applications Edaravone inhibits the disease activity in rheumatoid arthritis. Edaravone can significantly enhance IR flap viability and protect flap vessels, which is related to scavenging oxygen free radicals, reducing the consumption of SOD, reducing the extent of lipid peroxidation and inflammation, and protecting functional structure of vessels in the early stages of reperfusion. It also shows protective effects against STZ-induced cognitive impairment, oxidative stress, cholinergic dysfunction and altered protein expressions. Its acts like a free radical scavenger, decreased apoptotic cell death, oxidative damage to DNA and lipids, and angiogenesis through inhibiting JNK and p38 MAPK pathways in AMD, glaucoma, DR, and RVO animal models.<br>References Reeta KH et al. Eur J Neurosci. 2017 Feb 15Masuda T et al. Oxid Med Cell Longev. 2017;2017:9208489Zhang DY et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):51-56Criswell LA et al. Am J Med. 2002 Apr 15;112(6):465-71.<br></p>Fórmula:C10H10N2OForma y color:NeatPeso molecular:174.203-Methyl-1-phenyl-2-pyrazoline-5-one
CAS:Fórmula:C10H10N2OPureza:95%Forma y color:SolidPeso molecular:174.203Edaravone
CAS:<p>Edaravone is a drug that belongs to the class of radical scavengers and has been shown to be effective in reducing neuronal death by blocking the mitochondrial permeability transition pore. It also protects against oxidative injury by inhibiting lipid peroxidation, protein nitration, and DNA damage. Edaravone has been shown to be effective in treating bowel disease and possibly other inflammatory diseases such as sepsis. Edaravone is injected intravenously and can be used as an injection solution with dextran sulfate due to its low solubility in water. Edaravone binds reversibly to the toll-like receptor 4 (TLR4) and inhibits TLR4-mediated signaling pathways, which may lead to a reduction of inflammation.</p>Fórmula:C10H10N2OPureza:Min. 98%Forma y color:PowderPeso molecular:174.2 g/molEdaravone
CAS:<p>Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structure</p>Fórmula:C10H10N2OPeso molecular:174.07931















